Lineage Cell Therapeutics... (LCTX)
undefined
undefined%
At close: undefined
0.51
0.80%
After-hours Dec 13, 2024, 08:00 PM EST

Lineage Cell Therapeutics Inc. Forcast

Stock Price Forecast

The 4 analysts with 12-month price forecasts for LCTX stock have an median target of 5, with a low estimate of 2 and a high estimate of 9. The median target predicts an increase of 900.00% from the current stock price of 0.50.

Analyst Consensus: Buy
Target Low Average Median High
Price $2 $5.25 $5 $9
Change 300.00% 950.00% 900.00% 1700.00%

AI Analyst Report

HC Wainwright & Co. maintains a Buy rating on Line... Unlock content with Pro Subscription

Updated Dec 04, 2024

Rating Feb 24Mar 24May 24Aug 24Nov 24Dec 24
Strong Buy 000001
Buy 211120
Hold 000000
Sell 000000
Strong Sell 000000
Total 2 1 1 1 2 1

Financial Forecast this Year

Revenue This Year
5.29M
from 8.95M
Increased by -40.8%
Revenue Next Year
8.34M
from 5.29M
Increased by 57.5%
EPS This Year
-0.15
from -0.12
Increased by -25%
EPS Next Year
-0.14
from -0.15
Increased by 6.7%